Literature DB >> 2266165

Expression of human beta-myosin heavy chain fragments in Escherichia coli; localization of actin interfaces on cardiac myosin.

P Eldin1, M Le Cunff, K W Diederich, T Jaenicke, B Cornillon, D Mornet, H P Vosberg, J J Léger.   

Abstract

A cDNA clone coding for an internal fragment of slow-cardiac beta-myosin heavy chain was isolated from a lambda gt10 human skeletal muscle library. Six overlapping cDNA subclones, which span myosin heavy chain subregions and presumably interact with actin, were derived from this clone, fused to a beta-galactosidase vector and expressed in Escherichia coli. Three of the subclones were obtained by PCR (polymerase chain reaction) which enables gene or cDNA fragments to be amplified independently of preexisting restriction sites. Initially, various experiments were carried out using a long MHC (myosin heavy chain) fusion protein containing the 50 kDa-20 kDa connecting region, the whole 20 kDa region and the short subfragment 2 region. This MHC fusion protein was chemically or proteolytically cleaved in the same conditions as the native myosin molecule. Whole and truncated forms of the MHC fusion protein were separated on polyacrylamide gels, electroblotted on nitrocellulose sheets and renatured. They were then assayed in overlay experiments with F-actin and/or myosin light chains in solution. Specific antibodies were used to detect interactions between heavy chain fragments and F-actin or light chains. We thus observed that one long heavy chain fragment synthesized by E. coli behaved like proteolytic or chemical MHC preparations made from native myosin molecules. Two chymotryptic fragments of the MHC fusion protein, which are soluble at low ionic strength, cosedimented with F-actin in solution. Our results demonstrate that, in actin overlay experiments with whole fusion proteins, interactions seem to be due to the heavy chain fragment, not to the bacterial component. All interactions were non ATP-sensitive. We further investigated the possible participation of the six recombinant MHC fragments in contributing to the actomyosin interfaces on the 50 kDa-20 kDa regions of the human cardiac beta-MHC. The present procedure, which enables the synthesis of any MHC fragment independent of any protease site, is a powerful new tool for studying structure-function relationships within the myosin molecule family.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266165     DOI: 10.1007/bf01739759

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  54 in total

1.  Protein folding in mitochondria requires complex formation with hsp60 and ATP hydrolysis.

Authors:  J Ostermann; A L Horwich; W Neupert; F U Hartl
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

2.  Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene.

Authors:  I Karsch-Mizrachi; M Travis; H Blau; L A Leinwand
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

3.  Studies on the chymotryptic digestion of myosin. Effects of divalent cations on proteolytic susceptibility.

Authors:  A G Weeds; B Pope
Journal:  J Mol Biol       Date:  1977-04       Impact factor: 5.469

4.  The amino-acid sequence of the alkali light chains of rabbit skeletal-muscle myosin.

Authors:  G Frank; A G Weeds
Journal:  Eur J Biochem       Date:  1974-05-15

Review 5.  Myosin structure and function in cell motility.

Authors:  H M Warrick; J A Spudich
Journal:  Annu Rev Cell Biol       Date:  1987

6.  Fiber types and myosin types in human atrial and ventricular myocardium. An anatomical description.

Authors:  P Bouvagnet; J Leger; F Pons; C Dechesne; J J Leger
Journal:  Circ Res       Date:  1984-12       Impact factor: 17.367

7.  Evidence that the N-terminal region of A1-light chain of myosin interacts directly with the C-terminal region of actin. A proton magnetic resonance study.

Authors:  I P Trayer; H R Trayer; B A Levine
Journal:  Eur J Biochem       Date:  1987-04-01

8.  Isolation and characterization of the N-terminal 23-kilodalton fragment of myosin subfragment 1.

Authors:  A Muhlrad
Journal:  Biochemistry       Date:  1989-05-02       Impact factor: 3.162

Review 9.  Functional sequences of the myosin head.

Authors:  D Mornet; A Bonet; E Audemard; J Bonicel
Journal:  J Muscle Res Cell Motil       Date:  1989-02       Impact factor: 2.698

10.  Location of the head-tail junction of myosin.

Authors:  D L Rimm; J H Sinard; T D Pollard
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

View more
  6 in total

1.  Probing myosin light chain 1 structure with monoclonal antibodies.

Authors:  B Cornillon; A M Cathiard; P Eldin; M Anoal; R Cardinaud; J P Liautard; M Le Cunff; D Mornet; F Pons; J Leger
Journal:  J Muscle Res Cell Motil       Date:  1992-06       Impact factor: 2.698

2.  Molecular charge dominates the inhibition of actomyosin in skinned muscle fibers by SH1 peptides.

Authors:  P B Chase; T W Beck; J Bursell; M J Kushmerick
Journal:  Biophys J       Date:  1991-08       Impact factor: 4.033

3.  Mapping of the actomyosin interfaces.

Authors:  P Eldin; M Le Cunff; H P Vosberg; D Mornet; J J Léger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

Review 4.  Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history.

Authors:  Christine E Seidman; J G Seidman
Journal:  Circ Res       Date:  2011-03-18       Impact factor: 17.367

5.  The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.

Authors:  P Eldin; M Le Cunff; D Mornet; J J Leger
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

6.  Muscle-specific accumulation of Drosophila myosin heavy chains: a splicing mutation in an alternative exon results in an isoform substitution.

Authors:  W A Kronert; K A Edwards; E S Roche; L Wells; S I Bernstein
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.